Photo from wikipedia
Although the Papanicolaou (Pap) test is the first‐line screening method for cervical cancer, it has low sensitivity for detection of human papillomavirus (HPV)‐infected cervical lesion compared to the HPV test.… Click to show full abstract
Although the Papanicolaou (Pap) test is the first‐line screening method for cervical cancer, it has low sensitivity for detection of human papillomavirus (HPV)‐infected cervical lesion compared to the HPV test. The aims of this study are to determine novel cytomorphologic parameters for HPV infection in patients previously diagnosed as negative for intraepithelial lesion or malignancy (NILM) and to comparatively analyze the detection performance of 3 HPV tests: nested PCR, the DNA Chip test, and the Liquid Beads Microarray (LBMA) assay.
Journal Title: Diagnostic Cytopathology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!